James Edgemond, CFO AND TREASURER at UNITED THERAPEUTICS Corp (UTHR), sold 10,000 shares at $573.91 ($5.8M) on 2026-04-16, disclosed to the SEC on 2026-04-17.
Scheduled sale ($5.8M) by CFO AND TREASURER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $573.91 | 520 | $298K | 5.2% |
| 2 | $574.73 | 1,680 | $966K | 16.7% |
| 3 | $575.64 | 789 | $454K | 7.9% |
| 4 | $576.91 | 2,206 | $1.3M | 22.1% |
| 5 | $577.87 | 2,085 | $1.2M | 20.9% |
| 6 | $578.83 | 1,066 |
| $617K |
| 10.7% |
| 7 | $579.64 | 1,454 | $843K | 14.6% |
| 8 | $581.08 | 160 | $93K | 1.6% |
| 9 | $581.64 | 40 | $23K | 0.4% |
| Total | $577.18 avg | 10,000 | $5.8M | 100% |
| Filing → |
| UTHR | SELL | 2026-06-16 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-12 | $5.5M | — | Filing → |
| UTHR | SELL | 2026-06-09 | $5.5M | — | Filing → |